相关实验视频

Updated: May 3, 2026

A Biomimetic Model for Liver Cancer to Study Tumor-Stroma Interactions in a 3D Environment with Tunable Bio-Physical Properties

A Biomimetic Model for Liver Cancer to Study Tumor-Stroma Interactions in a 3D Environment with Tunable Bio-Physical Properties

Published on: August 7, 2020

停止肝细胞癌:在HBV驱动的疾病中识别细胞间交叉声

Lingyun Zhou¹, Chang-Hai Liu¹, Duoduo Lv¹

¹Center of Infectious Diseases, West China Hospital of Sichuan University, Chengdu, China.

|March 31, 2025

概括

乙型肝炎病毒 (HBV) 通过促进细胞交叉通话来驱动肝纤维化和癌症. 抑制ATR-NAMPT-INSR-PARP1通路阻断了这种进展,为慢性HBV感染提供了一个新的策略.

科学领域:

肝病学肝病学是一种肝病学.
在瘤学瘤学.
病毒学病毒学

背景情况:

乙型肝炎病毒 (HBV) 感染是肝纤维化和肝细胞癌 (HCC) 的主要原因.
抗病毒疗法并不能在所有患者中预防HCC的发展.
了解HBV诱导的细胞交叉对控制肝病进展至关重要.

研究的目的:

为了研究HBV诱导的肝细胞-肝星状细胞 (HSC) 交叉的机制.
确定这种交叉在肝纤维化和HCC发展中的作用.
在这个途径中识别潜在的治疗点.

主要方法:

使用MYC驱动的肝癌干细胞器官,HCC患者衍生异种移植 (PDX) 模型和HBV复制模型.
分析了HBV转录对肝细胞发育,DNA修复和糖解的影响.
研究了通过ATR激活尼古丁胺酸转移酶 (NAMPT) 的活性及其下游效应.

主要成果:

乙型肝炎病毒的转录影响了肝细胞的发育,激活了DNA修复,并促进了葡萄糖分解.
乙型肝炎病毒通过ATR激活了NAMPT,启动了NAMPT-胰岛素受体 (INSR) 介导的交叉声.
这种交叉诱导了HSC肌纤维细胞的分化,并通过PARP1乳化激活了端粒维护.

结论:

抑制ATR-NAMPT-INSR-PARP1通路有效地阻断HBV诱导的肝纤维化和HCC.
准这种途径为慢性HBV感染提供了一个有希望的治疗策略.
这项研究阐明了一种驱动HBV相关肝病理的新机制.

关键词:

CP: 癌症癌症癌症 CP: 微生物学微生物学在PARP1乳化中.肝脏的恒星细胞.肝脏纤维化肝脏纤维化一个单细胞RNA测序.端粒维护机制端粒维护机制

更多相关视频

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

相关概念视频

Diseases of the Liver and Gallbladder

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...

Hepatitis

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver.

Viral Hepatitis I: Introduction

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion...